Vistagen Therapeutics Inc. – Transcripts

NASDAQ: VTGN
Share price (10/7/26): $0.25
Market cap (10/7/26): $11.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Other Revised 09/21/26 Vistagen Therapeutics, Inc. - Shareholder/Analyst Call 09/10/26

Other Revised 07/06/26 Vistagen Therapeutics, Inc. - Special Call 06/30/26

Earnings Revised 02/24/26 Vistagen Therapeutics, Inc., Q3 2026 Earnings Call, Feb 12, 2026 02/12/26

CY 2025

Earnings Revised 11/13/25 Vistagen Therapeutics, Inc., Q2 2026 Earnings Call, Nov 13, 2025 11/13/25

Earnings Revised 08/08/25 Vistagen Therapeutics, Inc., Q1 2026 Earnings Call, Aug 07, 2025 08/07/25

Earnings Revised 06/24/25 Vistagen Therapeutics, Inc., 2025 Earnings Call, Jun 17, 2025 06/17/25

Earnings Revised 02/13/25 Vistagen Therapeutics, Inc., Q3 2025 Earnings Call, Feb 13, 2025 02/13/25

CY 2024

Earnings Revised 11/07/24 Vistagen Therapeutics, Inc., Q2 2025 Earnings Call, Nov 07, 2024 11/07/24

Earnings Revised 08/13/24 Vistagen Therapeutics, Inc., Q1 2025 Earnings Call, Aug 13, 2024 08/13/24

Earnings Revised 06/11/24 Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 06/11/24

Earnings Revised 02/13/24 Vistagen Therapeutics, Inc., Q3 2024 Earnings Call, Feb 13, 2024 02/13/24

CY 2023

Earnings Revised 11/27/23 Vistagen Therapeutics, Inc., Q2 2024 Earnings Call, Nov 09, 2023 11/09/23

Earnings Revised 08/11/23 Vistagen Therapeutics, Inc., Q1 2024 Earnings Call, Aug 10, 2023 08/10/23

Earnings Revised 06/28/23 Vistagen Therapeutics, Inc., 2023 Earnings Call, Jun 28, 2023 06/28/23

Earnings Revised 02/07/23 VistaGen Therapeutics, Inc., Q3 2023 Earnings Call, Feb 07, 2023 02/07/23

CY 2022

Earnings Revised 11/10/22 VistaGen Therapeutics, Inc., Q2 2023 Earnings Call, Nov 10, 2022 11/10/22

Other Revised 05/16/24 VistaGen Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11:45 AM 09/13/22

Earnings Revised 08/11/22 VistaGen Therapeutics, Inc., Q1 2023 Earnings Call, Aug 11, 2022 08/11/22

Earnings Revised 06/23/22 VistaGen Therapeutics, Inc., 2022 Earnings Call, Jun 23, 2022 06/23/22

Earnings Revised 02/10/22 VistaGen Therapeutics, Inc., Q3 2022 Earnings Call, Feb 10, 2022 02/10/22